Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

OREX 6.78 -1.23 (-15.36%)
price chart
Stock to Focus Orexigen Therapeutics, Inc. (NASDAQ:OREX)
Orexigen Therapeutics, Inc. (NASDAQ:OREX) as a �perilous reversal� (up big yesterday but down big today) candidate.
Why Lumber Liquidators Holdings Inc (LL), Orexigen Therapeutics, Inc. (OREX ...  Investorplace.com
Stocks Losing their Charm - AbbVie Inc (NYSE:ABBV), Orexigen Therapeutics ...  wsnewspublishers
Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch
The launch of Orexigen Therapeutics' (NASDAQ: OREX ) obesity drug Contrave was nothing to get too excited about. In the fourth quarter, which included 10 weeks of the launch, net sales of the drug were just $6.5 million, which resulted in $1.3 million ...
UPDATE: Orexigen Therapeutics Shares Drop After Q4 Results  Benzinga
Orexigen Therapeutics Inc. (NASDAQ:OREX) on Watch  Markets Wired
Orexigen Therapeutics (OREX) In A Perilous Reversal
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Buzz Stocks: Apple Inc., Orexigen Therapeutics, Inc., and Calithera ...
As such, Orexigen Therapeutics, Inc. -- which closed at $8.01 yesterday -- is pointed 12.2% lower ahead of the bell.
Orexigen: Contrave Scripts Dip With Sector
Orexigen (NASDAQ:OREX) saw a small dip in scripts in the most recent week. In addition, the company reported its quarterly results which indicated that the first 10 weeks of Contrave sales brought $1.3 million in royalty revenue.
Orexigen Therapeutics Inc. (OREX) is Trading Higher on Unusual Volume for ...
Orexigen Therapeutics Inc. ($OREX) experienced unusually high volume on Mar. 04, as the stock gained 11.13% to a closing price of $8.49.
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces ...
NEW YORK, March 6, 2015 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Orexigen Therapeutics, Inc. ("Orexigen" or the "Company") (NasdaqGS: OREX ...
Benzinga's Top #PreMarket Losers
Checkpoint Systems Inc. (NYSE: CKP) shares declined 18.17% to $10.99 in pre-market trading. Checkpoint Systems reported Q4 earnings of $0.26 per share on revenue of $183.11 million and issued a weak FY15 outlook.
Hottest Stocks On Wall Street: Orexigen Therapeutics, Inc. (NASDAQ:OREX ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) skyrocketed 31.95% yesterday and was extending gains in pre-market trading on Wednesday after the chemical company announced a new partnership with Honeywell International Inc. (NYSE:HON).
Upside to the Shares of Orexigen Therapeutics, Inc.(NASDAQ:OREX), Aruba ...  NIS
Orexigen: Contrave Script Sales Dip. Why?
Orexigen (NASDAQ:OREX) investors saw the second week of script performance that was below par. Last week's total scripts saw a modest 2% gain, while this week saw a 0.6% decline.